YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. government agreed to pay $1.2 billion to AstraZeneca PLC to secure its supply of a potential COVID-19 vaccine.
The deal calls for the government to fund a 30,000-person vaccine trial starting this summer. The investment also would support the ramp-up of manufacturing capacity to make at least 300 million doses.
The vaccine was developed by the University of Oxford’s Jenner Institute.
Read more from MarketWatch.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects